Clinical Trial Update: Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated capecitabine plus oxaliplatin in patients with advanced or metastatic pancreatic adenocarcinoma; the study has completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-10